Anemia Treatment Market: Global Industry Analysis and Forecast (2022-2029)

Anemia Treatment Market size was valued at US$ 6.67 Mn. in 2021 and the total revenue is expected to grow at 5.9 % through 2021 to 2029, reaching nearly US$ 10.55  Mn.

Anemia Treatment Market Overview:

Anemia is a disorder in which your body's tissues don't get enough oxygen because the human body doesn’t have enough healthy red blood cells. Anemia, commonly known as low hemoglobin, can leave you feeling exhausted and weak. Anemia comes in a variety of forms, each with its cause. Anemia can be short-term or long-term, and it can be mild or severe. Anemia is caused by a variety of factors in the majority of cases. Global Anemia Treatment MarketTo know about the Research Methodology :- Request Free Sample Report

Anemia Treatment Market Dynamics:

The global market for Anemia therapy is predicted to rise rapidly over the forecast period, owing to rising Anemia cases, expanding Anemia drug pipelines, and an increase in the number of women of reproductive age. Anemia affects over a third of the world's population, according to the National Institute of Health, and contributes to increased morbidity and death, decreased job productivity, and impaired brain development. Children under the age of five and pregnant women are the most sensitive populations to this disease. Efforts are being done to alleviate the disease's burden. The rising incidence of Anemia across various groups of society, including newborns, teenagers, and pregnant women, has become a global issue, prompting the government to establish numerous awareness-raising initiatives and activities to minimize Anemia prevalence among its people. As a result, the global iron deficiency Anemia therapy market is being driven by a preference for social health care over women's health in terms of Anemia. Most worldwide businesses are present in the anemia treatment market, which is moderately competitive. Companies are directing their efforts on creating anemia-treating medications or therapies hence these factors are likely to lift the market in the future. Further, strict rules and regulations play an important role in the pharmaceutical industry due to standard guidelines and procedures and are likely to obstruct the entry of budding players into the market. However, few small to mid-sized businesses are expected to enter the market in the future and earn a significant share.

Anemia Treatment Market Segment Analysis:

The Iron Deficiency Anemia segment is anticipated to adhere to the growth of the Anemia Treatment Market. The most prevalent type of Anemia is iron deficiency anemia, which occurs when the blood lacks enough red blood cells to transport oxygen to the body's tissues. Iron Deficiency Anemia, according to the National Institute of Health, is one of the most common nutritional deficiency conditions, affecting substantial segments of the population, notably physiological groups such as children, menstrual women, and pregnant women. Iron deficiency Anemia is also a problem in Asian countries like India and China, where the disease is becoming more prevalent among women. As a result, it is expected that the category would increase steadily throughout the projection period. Moreover, there are various treatment options available for Anemia such as Iron Supplement, balance Diet, and blood transfusion are likely to surge in market expansion.

Anemia Treatment Market Regional Segment:

North America is projected to lead the growth of the regional segment in the Anemia Treatment Market. The total Anemia treatment market was led by North America, with the United States being the leading contributor. Iron deficiency Anemia is extremely common among pregnant women and children, according to a 2018 study published in Mechanisms of Ageing and Development. In the United States, iron deficiency Anemia affects around 10% of women of childbearing age, and one-third of children (12 months to 36 months) are at risk. Furthermore, the growing number of product approvals for Anemia therapy is likely to be a substantial driver to the market. For example, Pharmacosmos AS recently received FDA clearance in the United States for their medicine "Monoferric" for the treatment of iron deficient Anemia. As a result, the high incidence rate of Anemia is likely to drive market expansion in North America. The objective of the report is to present a comprehensive analysis of the Anemia Treatment Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Anemia Treatment Market dynamics, structure by analyzing the market segments and project the Anemia Treatment Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Anemia Treatment Market make the report investor’s guide.

Anemia Treatment Market Scope: Inquire before buying

 
Global Anemia Treatment Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US $ 6.67 Mn.
Forecast Period 2022 to 2029 CAGR: 5.9% Market Size in 2029: US $ 10.55 Mn.
Segments Covered: by Product • Iron Deficiency Anemia • CKD Anemia • Sickle Cell Anemia • Aplastic Anemia • Others

Anemia Treatment Market, by Region

• North America o US o Canada o Mexico • Europe o U.K o France o Germany o Italy o Spain o Sweden o CIS Countries o Rest of Europe • Asia Pacific o China o India o Japan o South Korea o Australia o ASEAN o Rest of Asia Pacific • The Middle East and Africa o South Africa o GCC Countries o Egypt o Nigeria o Rest of ME&A • South America o Brazil o Argentina o Rest of South America

Anemia Treatment Market Key Players

AbbVie Inc. • Allergan, Inc. • Bayer AG • Amgen Inc. • GlaxoSmithKline Plc • Biocon • Bluebird Biod • Regen Biopharma Inc. • Acceleron Pharma • Eli Lilly and Company • Sanofi • Pharmacosmos A/S • ViforPharma Ltd. • AMAG Pharmaceuticals • Fresenius SE & CO. KGAA • Novartis AG • Lupin • Orion Coporoations • Akebia Therapeutics, INC. • Zydus Cadila • Rockwell Medical

FAQs:

1. What is the Anemia Treatment Market value in 2021? Ans: The Anemia Treatment Market value in 2021 was estimated as 6.67 Billion USD. 2. What is the Anemia Treatment Market growth? Ans: The Anemia Treatment Market is anticipated to grow with a CAGR of 5.9% in the forecast period and is likely to reach USD 10.55 Billion by the end of 2029. 3. Which Type of Diseases segment is expected to dominate the Anemia Treatment Market during the forecast period? Ans: Iron deficiency Anemia is the most common type of anemia in which the blood does not have adequate amount of red blood cells which carry oxygen to the body's tissues. 4. Who are the key players of Anemia Treatment Market? Ans: Leading market player of the Anemia Treatment Market are AbbVie Inc., Allergan, Inc., Bayer AG, Bristol-Myers Squibb, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche, Eli Lilly and Co., GlaxoSmithKline plc, Janssen Biotech, Inc., Johnson & Johnson, Novartis International AG, Pfizer Inc., Sanofi, and Takeda Pharmaceutical Company Limited. 5. What is the key driving factor for the growth of the Anemia Treatment Market? Ans: Key factors that are driving the Anemia Treatment market growth include the Growing prevalence of the disease, along with increase in number of pipeline drugs, is expected to be a key factor driving the market.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Technology 2.3.2. Primary Research 2.3.2.1. Data from Primary Technology 2.3.2.2. Breakdown of Primary Technology 3. Executive Summary: Anemia Treatment Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2020 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Anemia Treatment Market 3.4. Geographical Snapshot of the Anemia Treatment Market, By Manufacturer share 4. Anemia Treatment Market Overview, 2021-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porter Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Grades 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Anemia Treatment Market 5. Supply Side and Demand Side Indicators 6. Anemia Treatment Market Analysis and Forecast, 2021-2029 6.1. Anemia Treatment Market Size & Y-o-Y Growth Analysis. 7. Anemia Treatment Market Analysis and Forecasts, 2021-2029 7.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 7.1.1. Iron Deficiency Anemia 7.1.2. CKD (Chronic Kidney Disease) Anemia 7.1.3. Sickle Cell Anemia 7.1.4. Aplastic Anemia 7.1.5. Others 8. Anemia Treatment Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2021-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Anemia Treatment Market Analysis and Forecasts, 2021-2029 9.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 9.1.1. Iron Deficiency Anemia 9.1.2. CKD (Chronic Kidney Disease) Anemia 9.1.3. Sickle Cell Anemia 9.1.4. Aplastic Anemia 9.1.5. Others 10. North America Anemia Treatment Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Anemia Treatment Market Analysis and Forecasts, 2021-2029 11.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 12. Canada Anemia Treatment Market Analysis and Forecasts, 2021-2029 12.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 13. Mexico Anemia Treatment Market Analysis and Forecasts, 2021-2029 13.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 14. Europe Anemia Treatment Market Analysis and Forecasts, 2021-2029 14.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 15. Europe Anemia Treatment Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Anemia Treatment Market Analysis and Forecasts, 2021-2029 16.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 17. France Anemia Treatment Market Analysis and Forecasts, 2021-2029 17.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 18. Germany Anemia Treatment Market Analysis and Forecasts, 2021-2029 18.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 19. Italy Anemia Treatment Market Analysis and Forecasts, 2021-2029 19.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 20. Spain Anemia Treatment Market Analysis and Forecasts, 2021-2029 20.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 21. Sweden Anemia Treatment Market Analysis and Forecasts, 2021-2029 21.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 22. CIS Countries Anemia Treatment Market Analysis and Forecasts, 2021-2029 22.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 23. Rest of Europe Anemia Treatment Market Analysis and Forecasts, 2021-2029 23.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 24. Asia Pacific Anemia Treatment Market Analysis and Forecasts, 2021-2029 24.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 25. Asia Pacific Anemia Treatment Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Anemia Treatment Market Analysis and Forecasts, 2021-2029 26.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 27. India Anemia Treatment Market Analysis and Forecasts, 2021-2029 27.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 28. Japan Anemia Treatment Market Analysis and Forecasts, 2021-2029 28.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 29. South Korea Anemia Treatment Market Analysis and Forecasts, 2021-2029 29.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 30. Australia Anemia Treatment Market Analysis and Forecasts, 2021-2029 30.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 31. ASEAN Anemia Treatment Market Analysis and Forecasts, 2021-2029 31.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 32. Rest of Asia Pacific Anemia Treatment Market Analysis and Forecasts, 2021-2029 32.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 33. Middle East Africa Anemia Treatment Market Analysis and Forecasts, 2021-2029 33.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 34. Middle East Africa Anemia Treatment Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Anemia Treatment Market Analysis and Forecasts, 2021-2029 35.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 36. GCC Countries Anemia Treatment Market Analysis and Forecasts, 2021-2029 36.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 37. Egypt Anemia Treatment Market Analysis and Forecasts, 2021-2029 37.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 38. Nigeria Anemia Treatment Market Analysis and Forecasts, 2021-2029 38.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 39. Rest of ME&A Anemia Treatment Market Analysis and Forecasts, 2021-2029 39.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 40. South America Anemia Treatment Market Analysis and Forecasts, 2021-2029 40.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 41. South America Anemia Treatment Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Anemia Treatment Market Analysis and Forecasts, 2021-2029 42.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 43. Argentina Anemia Treatment Market Analysis and Forecasts, 2021-2029 43.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 44. Rest of South America Anemia Treatment Market Analysis and Forecasts, 2021-2029 44.1. Market Size (Value) Estimates & Forecast By Type of Diseases, 2021-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Anemia Treatment Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades, and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment, and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1. Pfizer 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Amgen Inc. 45.3.3. GlaxoSmithKline Plc 45.3.4. Biocon 45.3.5. Bluebird Biod 45.3.6. Regen Biopharma Inc. 45.3.7. Bayer AG 45.3.8. Acceleron Pharma 45.3.9. Eli Lilly and Company 45.3.10. Sanofi 45.3.11. AbbVie Inc 45.3.12. Pharmacosmos A/S 45.3.13. ViforPharma Ltd. 45.3.14. AMAG Pharmaceuticals 45.3.15. Fresenius SE & CO. KGAA 45.3.16. Novartis AG 45.3.17. Lupin 45.3.18. Orion Corporation 45.3.19. Akebia Therapeutics, INC. 45.3.20. Zydus Cadila 45.3.21. Rockwell Medical 46. Primary Key Insights
  • INQUIRE BEFORE BUYING